Evidence map›Paper›PMID 33397806›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

LGI1-ADAM22-MAGUK configures transsynaptic nanoalignment for synaptic transmission and epilepsy prevention.

Yuko Fukata, Xiumin Chen, Satomi Chiken, Yoko Hirano, Atsushi Yamagata, Hiroki Inahashi, Makoto Sanbo, Hiromi Sano, Teppei Goto, Masumi Hirabayashi and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Nonionic signaling rapidly remodels postsynaptic DLG to induce retrograde homeostatic plasticity.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Competitive modulation of KFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  14. Article
  15. Review
  16. LGI1 Autoantibodies Enhance Synaptic Transmission by Presynaptic KNeurology(R) neuroimmunology & neuroinflammation · 2024
    Article
  17. OPALIN is an LGI1 receptor promoting oligodendrocyte differentiation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  18. Review
  19. Article
  20. Structural and functional reorganization of inhibitory synapses by activity-dependent cleavage of neuroligin-2.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Yuko FukataDivision of Membrane Physiology, Department of Molecular and Cellular Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi 444-8787, Japan.ORCID 0000-0001-7724-8643
Xiumin ChenDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158.
Satomi ChikenDepartment of Physiological Sciences, School of Life Science, SOKENDAI (The Graduate University for Advanced Studies), Aichi 444-8585, Japan.
Yoko HiranoDivision of Membrane Physiology, Department of Molecular and Cellular Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi 444-8787, Japan.
Atsushi YamagataLaboratory for Protein Functional and Structural Biology, RIKEN Center for Biosystems Dynamics Research, Kanagawa 230-0045, Japan.
Hiroki InahashiDivision of Membrane Physiology, Department of Molecular and Cellular Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi 444-8787, Japan.
Makoto SanboCenter for Genetic Analysis of Behavior, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Okazaki 444-8787, Japan.ORCID 0000-0001-8806-1745
Hiromi SanoDepartment of Physiological Sciences, School of Life Science, SOKENDAI (The Graduate University for Advanced Studies), Aichi 444-8585, Japan.ORCID 0000-0001-7347-8150
Teppei GotoCenter for Genetic Analysis of Behavior, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Okazaki 444-8787, Japan.ORCID 0000-0002-0081-3357
Masumi HirabayashiDepartment of Physiological Sciences, School of Life Science, SOKENDAI (The Graduate University for Advanced Studies), Aichi 444-8585, Japan.ORCID 0000-0002-1059-5883
Hans-Christian KornauGerman Center for Neurodegenerative Diseases (DZNE), 10117 Berlin, Germany.ORCID 0000-0003-4187-7549
Harald PrüssGerman Center for Neurodegenerative Diseases (DZNE), 10117 Berlin, Germany.ORCID 0000-0002-8283-7976
Atsushi NambuDepartment of Physiological Sciences, School of Life Science, SOKENDAI (The Graduate University for Advanced Studies), Aichi 444-8585, Japan.ORCID 0000-0003-2153-5445
Shuya FukaiDepartment of Chemistry, Graduate School of Science, Kyoto University, 606-8502 Kyoto, Japan.ORCID 0000-0002-1241-1443
Roger A NicollDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158; nicoll@cmp.ucsf.edu mfukata@nips.ac.jp.
Masaki FukataDivision of Membrane Physiology, Department of Molecular and Cellular Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi 444-8787, Japan; nicoll@cmp.ucsf.edu mfukata@nips.ac.jp.ORCID 0000-0001-5200-9806
National Institutes of Natural Sciences · JPGerman Center for Neurodegenerative Diseases · DEUniversity of California, San Francisco · USKyoto University · JPRIKEN Center for Biosystems Dynamics Research · JP

Funding

The synaptic cleft and glutamate receptor traffickingR01MH117139 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NICOLL, ROGER A · 2018 to 2022
$2.9M
NIMH NIH HHS R01 MH117139
6 · The paper itself

Abstract

Physiological functioning and homeostasis of the brain rely on finely tuned synaptic transmission, which involves nanoscale alignment between presynaptic neurotransmitter-release machinery and postsynaptic receptors. However, the molecular identity and physiological significance of transsynaptic nanoalignment remain incompletely understood. Here, we report that epilepsy gene products, a secreted protein LGI1 and its receptor ADAM22, govern transsynaptic nanoalignment to prevent epilepsy. We found that LGI1-ADAM22 instructs PSD-95 family membrane-associated guanylate kinases (MAGUKs) to organize transsynaptic protein networks, including NMDA/AMPA receptors, Kv

Indexed as

ADAM ProteinsAnimalsBrainCalcium-Binding ProteinsDisease Models, AnimalEpilepsyGene Knock-In TechniquesGuanylate KinasesHippocampusHumansIntracellular Signaling Peptides and ProteinsMembrane ProteinsMiceNerve Tissue ProteinsNeural Cell Adhesion MoleculesReceptors, AMPAAdam22 protein, mouseADAM ProteinsCalcium-Binding ProteinsGuanylate KinasesIntracellular Signaling Peptides and ProteinsLgi1 protein, mouseLRRTM4 protein, mouseMembrane ProteinsNerve Tissue ProteinsNeural Cell Adhesion MoleculesNrxn1 protein, mouseReceptors, AMPAReceptors, N-Methyl-D-AspartateShaker Superfamily of Potassium ChannelsAMPA receptorepilepsyLGI1–ADAM22MAGUKtranssynaptic nanocolumn

Identifiers

PMID33397806
PMCPMC7826393
OpenAlexW3120307467

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.